Preliminary studies suggest conolidine may well inhibit certain ion channels, reducing neuronal excitability and limiting soreness alerts. This mechanism is particularly appropriate in neuropathic soreness, exactly where irregular signaling results in persistent soreness. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) p